Firms ally to develop drugs for rare genetic disorders

Nimbus Discovery and Shire agreed to collaborate in the discovery and development of small molecule drugs for lysosomal storage disorders using the former's computational chemistry platform. Nimbus will be in charge of discovery, and Shire will handle clinical development and commercialization. The deal entitles Nimbus to undisclosed milestone payments.

View Full Article in:

Genetic Engineering & Biotechnology News · Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA